INFORMED.
LIVE

Vivimed Labs Ltd.

BSE: VIVIMEDLAB532660ISIN INE526G01021
  • Healthcare
  • Pharmaceuticals

Share price

₹5.73-0.11 (-1.88%)
as of 18 Sep 2026
Vivimed Labs Ltd. share price, 18 Dec 2025 to 18 Sep 2026: ₹26.51 to ₹5.73 (-78.4%). Low ₹4.92, high ₹26.51. Volume shown below the price.
52W high
₹27.99
52W low
₹4.76
Off 52W high
-79.53%
1M return
+1.06%
3M return
-3.37%
6M return
-9.62%
1Y return
20D avg volume
11,032
50 DMA
₹5.70
200 DMA

Key ratios Consolidated

Market cap
₹47.51 Cr
Current price
₹5.73
52W high / low
₹27.99 / ₹4.76
Face value
₹2.00
P/E
-0.27
P/B
EPS (TTM)
₹-21.15
Book value / share
ROE
ROCE
-56.00%
Operating margin
Net margin
Debt / equity
-1.89
Net debt
₹397.24 Cr
Interest cover
-41.03
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
25.1 days

Financials

MetricQ4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
12.0015.9920.6121.3925.61
5.750.000.210.384.22
163.6532.5428.1327.2634.84
7.918.935.3010.777.76
0.000.000.000.000.00
9.973.695.605.718.79
0.951.001.660.581.74
11.514.634.905.01
94.2915.326.856.177.38
-145.90-16.55-7.30-5.49
0.000.000.000.00
-145.90-16.55-7.30-5.49-5.01
0.140.000.000.000.11
-146.03-16.55-7.30-5.49-5.13
-17.74-0.88-0.88-0.66-0.67
Key metrics
-133.44-10.92-0.740.10-3.27
-1,112.00%-68.30%-3.60%0.50%-12.80%
-1,216.90%-103.50%-35.40%-25.70%-20.00%
-47.50%-1.20%-0.60%
-53.10%
-2,746.60%
MetricTTMFY26FY25FY24
Income statement
69.9969.99116.27
6.346.324.37
251.58251.56152.03
32.9132.9157.76
0.000.000.00
24.9724.9728.39
4.194.172.95
26.0526.05
122.63122.6240.61
-175.24-175.25
0.000.00
-175.24-175.25-31.39
0.140.140.11
-175.37-175.38-31.50
-20.16-21.15-3.85
Key metrics
-145.00-145.03-28.44
-207.17%-207.20%-24.50%
-250.56%-250.60%-27.10%
-56.00%-5.50%
-39.80%
-456.80%
7.70-15.34
-0.040.34
-1.89
397.24
25.1293.4
Balance sheet
753.48920.83
168.00327.56
0.070.71
45.3374.11
12.7158.76
63.4898.53
237.01254.40
53.2439.42
448.11408.20
397.31
325.80
71.51
-210.55
Cash flow
7.70-10.81
-0.954.53
-6.114.96
0.00-4.53
MetricQ4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
7.5511.6318.6617.9422.57
0.000.000.160.364.15
148.7328.2026.2623.8030.56
9.306.966.0110.1112.34
0.000.000.000.000.00
8.642.684.584.517.07
0.790.941.600.521.48
4.304.404.684.80
89.1314.245.574.835.89
-141.18-16.57-7.45-5.50
0.000.000.000.00
-141.18-16.57-7.45-5.50-3.84
0.000.000.000.000.00
-141.18-16.57-7.45-5.50-3.84
-17.14-2.00-0.90-0.66-0.60
Key metrics
-136.09-11.23-1.17-0.18-2.36
-1,802.50%-96.60%-6.30%-1.00%-10.50%
-1,869.90%-142.50%-39.90%-30.70%-17.00%
-174.70%-2.50%-1.00%
-66.50%
-3,576.60%
MetricTTMFY26FY25FY24
Income statement
55.7855.78103.60
0.520.514.18
226.99226.98138.71
32.3832.3960.12
0.000.000.00
20.4120.4123.04
3.853.862.53
18.1818.19
113.77113.7636.16
-170.70-170.68
0.000.00
-170.70-170.68-30.92
0.000.000.00
-170.70-170.68-30.92
-20.70-20.593.87
Key metrics
-148.67-148.63-28.39
-266.53%-266.50%-27.40%
-306.02%-306.00%-29.80%
-207.60%-11.60%
-46.20%
-452.00%
4.455.74
-0.03-0.19
-3.46
388.04
16.7241.9
Balance sheet
502.16638.95
142.45247.78
0.070.29
43.3745.80
10.8356.50
63.1283.04
231.42247.87
51.6533.65
421.81393.21
388.11
316.75
71.36
-112.19
Cash flow
4.455.74
-0.11-4.06
-4.55-2.53
0.000.00

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results